BRIEF-Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing To Support Lead Program, Cnty-813

Reuters

Jan 08

BRIEF-Century <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Secures Oversubscribed $135 Million Private Placement Financing To Support Lead Program, Cnty-813

Jan 8 (Reuters) - Century Therapeutics Inc IPSC.O:

CENTURY THERAPEUTICS SECURES OVERSUBSCRIBED $135 MILLION PRIVATE PLACEMENT FINANCING TO SUPPORT LEAD PROGRAM, CNTY-813, A POTENTIALLY CURATIVE THERAPY FOR TYPE 1 DIABETES
CENTURY THERAPEUTICS INC - FINANCING LED BY TCGX WITH MULTIPLE INVESTORS PARTICIPATING

Source text: ID:nGNX3b4YdB

Further company coverage: IPSC.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2601362326"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2601362326\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2601362326?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-08 21:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601362326","market":"us","top_or_hot":-1,"title":"BRIEF-Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing To Support Lead Program, Cnty-813","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Century <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Secures Oversubscribed $135 Million Private Placement Financing To Support Lead Program, Cnty-813</title></head><body><p><span>Jan 8 (Reuters)</span><span> - </span>Century Therapeutics Inc <span>IPSC.O</span>:</p><ul><li><p>CENTURY THERAPEUTICS SECURES OVERSUBSCRIBED $135 MILLION PRIVATE PLACEMENT FINANCING TO SUPPORT LEAD PROGRAM, CNTY-813, A POTENTIALLY CURATIVE THERAPY FOR TYPE 1 DIABETES</p></li><li><p>CENTURY THERAPEUTICS INC - FINANCING LED BY TCGX WITH MULTIPLE INVESTORS PARTICIPATING</p></li></ul><p>Source text: <span>ID:nGNX3b4YdB</span></p><p>Further company coverage: <span>IPSC.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing To Support Lead Program, Cnty-813</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing To Support Lead Program, Cnty-813\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-08 21:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Century <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Secures Oversubscribed $135 Million Private Placement Financing To Support Lead Program, Cnty-813</title></head><body><p><span>Jan 8 (Reuters)</span><span> - </span>Century Therapeutics Inc <span>IPSC.O</span>:</p><ul><li><p>CENTURY THERAPEUTICS SECURES OVERSUBSCRIBED $135 MILLION PRIVATE PLACEMENT FINANCING TO SUPPORT LEAD PROGRAM, CNTY-813, A POTENTIALLY CURATIVE THERAPY FOR TYPE 1 DIABETES</p></li><li><p>CENTURY THERAPEUTICS INC - FINANCING LED BY TCGX WITH MULTIPLE INVESTORS PARTICIPATING</p></li></ul><p>Source text: <span>ID:nGNX3b4YdB</span></p><p>Further company coverage: <span>IPSC.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA3JCCP3:1","article_id":"2601362326","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601362326","pubTimestamp":1767878500,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing To Support Lead Program, Cnty-813Jan 8 (Reuters) - Century Therapeutics Inc IPSC.O:CENTURY THERAPEUTICS SECUR","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","BK4505":"高瓴资本持仓","BK4139":"生物科技","IPSC":"Century Therapeutics, Inc."},"translate_title":"BRIEF-Century Therapeutics获得超额认购的1.35亿美元私募融资，以支持牵头项目Cnty-813","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IPSC":0.9},"content_text":"BRIEF-Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing To Support Lead Program, Cnty-813Jan 8 (Reuters) - Century Therapeutics Inc IPSC.O:CENTURY THERAPEUTICS SECURES OVERSUBSCRIBED $135 MILLION PRIVATE PLACEMENT FINANCING TO SUPPORT LEAD PROGRAM, CNTY-813, A POTENTIALLY CURATIVE THERAPY FOR TYPE 1 DIABETESCENTURY THERAPEUTICS INC - FINANCING LED BY TCGX WITH MULTIPLE INVESTORS PARTICIPATINGSource text: ID:nGNX3b4YdBFurther company coverage: IPSC.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}